ArticleFrontiers in immunology2026

Efficacy and safety of transarterial chemoembolization combined with donafenib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus: a dual-center, retrospective propensity score-matched analysis.

Qi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.